By ipomarket.in Editorial Team · Last reviewed: 2026-09-28
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.
Most retail investors walk into an IPO with one number in their head: how much they will make on listing day. That number is usually a guess, and often an inflated one. The good news is you do not have to guess. Years of public IPO data exist, and reading it properly helps you set expectations that match reality rather than social media hype.
This guide walks through the data points that actually matter, how they connect to listing day outcomes, and where the honest limits lie. None of this predicts the future. It just replaces wishful thinking with evidence.
What "listing gain" actually means
A listing gain is the percentage difference between an IPO's issue price and its listing price on the first day of trading. If shares are allotted at ₹100 and open at ₹120, that is a 20% listing gain. It can also be negative, which people conveniently forget when they build their expectations.
The key thing to understand is that a listing gain is a single-day event. It says almost nothing about whether the company is a good long-term holding. Keeping those two ideas separate is the foundation of realistic target setting.
The data that recent years give us
The cooling of the IPO market is visible in the numbers. According to an INDmoney review, the median listing gain fell sharply to 3.8% in 2025, down from 15.2% in 2024 and 16.5% in 2023. If your mental model of "normal" listing gains is stuck at 15% or higher, it is out of date.
The more sobering statistic: in 2025, roughly 65% of IPOs listed at a gain, yet by 31 December 2025, about 59% were trading below their listing price. Read that twice. Most listings were green on day one, but more than half had drifted below their listing price by year-end.
This is the single most important insight for setting targets. A strong debut and a strong investment are not the same thing. A stock can list at a 40-60% premium and still trade below its issue price six months later, while a quietly received listing can compound steadily. If you are counting on listing gains, you are betting on day one alone, not on the business.
Grey Market Premium: useful, but handle with care
Grey Market Premium (GMP) is the price at which IPO shares change hands in the unofficial market before listing. It is a rough gauge of demand, not a SEBI-regulated price.
One analysis of roughly 300 Indian IPOs reported a correlation of close to 0.8 between GMP and actual listing-day returns, with most IPOs listing within 15-20% of their grey-market implied price. That is a genuinely strong relationship, which is why GMP gets so much attention. The same analysis suggested that a GMP-implied gain above 30-60% almost always lined up with a strong positive listing, 15-20% still pointed to a high probability of gains, and below 5% or negative GMP often signalled a flat or weak debut.
The rough formula people use:
Expected Listing Gain % = (GMP ÷ Issue Price) × 100
If the issue price is ₹100 and GMP is ₹20, the implied listing gain is 20%.
Here is the honest part. GMP is unofficial, unregulated, thinly traded, and it moves fast, sometimes swinging in the final day before listing. A 0.8 correlation across 300 IPOs is strong but not a guarantee for the one IPO you happen to be looking at. Treat GMP as one input among several, not a forecast. Our detailed explainer on what IPO GMP is and how it works covers the mechanics in more depth.
Subscription data, especially QIB demand
Subscription numbers tell you how many times an issue was applied for across investor categories: Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII).
Institutional demand tends to carry more predictive weight than the blended overall subscription figure. Institutions do detailed due diligence, so heavy QIB participation is a signal worth weighing more than a retail-driven frenzy. A study of NSE-listed IPOs from January 2018 to December 2020 found that oversubscription influenced listing performance, while some other factors such as issue price and promoter holdings showed weaker links to returns in that sample.
When you read subscription data, do not just look at the headline "subscribed X times." Break it down by category. Our guide on IPO subscription status by QIB, NII, and retail explains how to interpret each bucket.
Market conditions decide more than you think
No IPO lists in a vacuum. A bullish Nifty and Sensex environment lifts almost every debut, while a broadly weak market can drag down even a fundamentally sound issue. This is why the same quality of company can deliver very different listing outcomes in different months.
Before you anchor to any target, check where the broader market is trading and whether sentiment is risk-on or risk-off. A GMP of 25% in a euphoric market and the same GMP in a nervous market are not the same signal.
A practical framework for reading past data
Here is how to put the pieces together instead of fixating on a single number.
1. Study the historical base rate
Start with the current environment's median, not the peak. With 2025's median listing gain at 3.8%, expecting 40% from an average issue is not realistic. Public trackers and exchange filings let you build this base rate yourself.
2. Layer in GMP, but discount it
Use GMP for a rough range, then mentally widen that range because grey market quotes are noisy. If GMP implies 20%, treat the realistic band as something wider on both sides, including the possibility of a flat or negative open.
3. Weight QIB subscription heavily
Strong, credible institutional demand supports a firmer debut than a retail-only surge. Weak QIB interest is a caution flag even when overall subscription looks large.
4. Check the market backdrop
Adjust your expectations up or down based on whether the market is broadly rising or falling in the days around listing.
5. Separate listing gain from investment thesis
Decide upfront whether you are in for the listing pop or the business. If it is the pop, your data work is about probability of a green open. If it is the business, listing gains are almost irrelevant and you should be reading the DRHP and financials instead.
Where to find the raw data
You do not need paid tools to do this. The NSE list of past IPO issues records each issue price, and exchange bhavcopy files capture listing-day opens and closes. Historical performance reports from data platforms consolidate subscription figures, listing gains, and post-listing trends. Public datasets covering hundreds of Indian IPOs from 2010 onward also exist for those who want to run their own analysis.
If you want to understand the company itself before worrying about listing day, our walkthrough on how to read a DRHP is a better starting point than any GMP tracker.
A note on the changing structure
Former SEBI chairperson Madhabi Puri Buch has been reported (in May 2026 coverage) to have indicated that the regulator was developing a "when-listed" platform allowing investors to trade allotted shares before official listing, with the aim of curbing grey market activity. This is described as proposed and under development, not implemented. If and when such a platform arrives, the role of GMP as an informal signal could change. Treat this as an unconfirmed development to watch, not a current feature.
The honest bottom line
Reading past IPO data will not hand you a guaranteed number. What it does is anchor your expectations to evidence. The median 2025 listing gain of 3.8%, the fact that most listings later slipped below their listing price, and the strong-but-imperfect GMP correlation all point in the same direction: modest, uncertain, and heavily dependent on market mood.
If you set targets from that reality rather than from a screenshot of someone else's gains, you will make calmer decisions. And if listing gains are your only reason for applying, the data quietly suggests being far more selective than the hype implies.
FAQ
Can GMP reliably predict my listing gain?
No. Across roughly 300 IPOs, GMP showed a strong correlation of about 0.8 with listing-day returns, but that is a broad tendency, not a guarantee for any single IPO. GMP is unofficial, thinly traded, and moves quickly, so use it as one input within a wider range rather than a precise forecast.
Why did so many 2025 IPOs fall below their listing price?
In 2025, about 65% of IPOs listed at a gain, but roughly 59% were trading below their listing price by 31 December 2025. Listing gains reflect day-one demand, while later performance reflects business fundamentals and market conditions. The two often diverge, which is why a strong debut does not guarantee a strong holding.
Which single data point matters most for listing day?
There is no single reliable one, but QIB (institutional) subscription tends to carry more predictive weight than blended overall subscription, because institutions do deeper due diligence. It should be read alongside GMP and the broader market environment rather than in isolation.
Where can I find past IPO data for free?
NSE and BSE publish past issue lists and bhavcopy files that record issue prices and listing-day opens and closes. Several financial platforms consolidate subscription figures and listing gain history, and public datasets covering hundreds of Indian IPOs from 2010 onward are also available.
Should I set a target before applying to an IPO?
It helps to define your goal upfront: are you after the listing gain or the long-term business. If it is the listing gain, your data work is about the probability of a green open. If it is the business, listing gains barely matter and you should focus on the DRHP and financials instead.
Last reviewed: 2026-09-28 by the ipomarket.in Editorial Team.